Alps Advisors Inc Supernus Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 07, 2021	SELL	$24.15 - $31.45 $288,181 - $375,292	-11,933 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$17.7 - $25.81 $6,425 - $9,369	-363 Reduced 2.95%	11,933 $300,000
Q3 2020 Nov 04, 2020	BUY	$20.2 - $25.05 $248,379 - $308,014	12,296 New	12,296 $256,000
Q3 2019 Nov 04, 2019	SELL	$25.47 - $33.37 $254,801 - $333,833	-10,004 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$29.96 - $38.87 $15,818 - $20,523	-528 Reduced 5.01%	10,004 $331,000
Q1 2019 May 01, 2019	BUY	$32.77 - $41.99 $21,824 - $27,965	666 Added 6.75%	10,532 $369,000
Q4 2018 Feb 04, 2019	SELL	$30.84 - $49.51 $2.86 Million - $4.59 Million	-92,794 Reduced 90.39%	9,866 $328,000
Q3 2018 Oct 25, 2018	BUY	$42.7 - $56.55 $754,252 - $998,899	17,664 Added 20.78%	102,660 $5.17 Million
Q2 2018 Aug 02, 2018	BUY	$44.1 - $59.85 $813,997 - $1.1 Million	18,458 Added 27.74%	84,996 $5.09 Million
Q2 2018 Jul 25, 2018	SELL	$44.1 - $59.85 $586,133 - $795,466	-13,291 Reduced 16.65%	66,538 $2.65 Million
Q1 2018 May 01, 2018	BUY	$37.15 - $46.9 $493,760 - $623,347	13,291 Added 19.98%	79,829 $3.66 Million
Q4 2017 Feb 05, 2018	BUY	$36.4 - $42.6 $191,573 - $224,203	5,263 Added 8.59%	66,538 $2.65 Million
Q3 2017 Nov 03, 2017	BUY	$36.75 - $49.65 $2.25 Million - $3.04 Million	61,275	61,275 $2.45 Million

303

60.7M

22.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.72B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.